111 related articles for article (PubMed ID: 33642282)
1. Diffusion Kurtosis Imaging Reflects GFAP, TopoIIα, and MGMT Expression in Astrocytomas.
Wang XC; Tan Y; Zhang H; Qin JB; Lei Y; Hao XY
Neurol India; 2021; 69(1):119-125. PubMed ID: 33642282
[TBL] [Abstract][Full Text] [Related]
2. Diffusion Kurtosis Imaging Reflects Glial Fibrillary Acidic Protein (GFAP), Topo IIα, and O⁶-Methylguanine-DNA Methyltransferase (MGMT) Expression in Astrocytomas.
Wang XC; Lei Y; Wang L; Tan Y; Qin JB; Ma GL; Zhang H
Med Sci Monit; 2018 Dec; 24():8822-8830. PubMed ID: 30520434
[TBL] [Abstract][Full Text] [Related]
3. Comparing the value of DKI and DTI in detecting isocitrate dehydrogenase genotype of astrocytomas.
Tan Y; Zhang H; Wang X; Qin J; Wang L; Yang G; Yan H
Clin Radiol; 2019 Apr; 74(4):314-320. PubMed ID: 30771996
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of high-grade-astrocytomas from solitary-brain-metastases: Comparing diffusion kurtosis imaging and diffusion tensor imaging.
Tan Y; Wang XC; Zhang H; Wang J; Qin JB; Wu XF; Zhang L; Wang L
Eur J Radiol; 2015 Dec; 84(12):2618-24. PubMed ID: 26482747
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the values of MRI diffusion kurtosis imaging and diffusion tensor imaging in cerebral astrocytoma grading and their association with aquaporin-4.
Tan Y; Zhang H; Zhao RF; Wang XC; Qin JB; Wu XF
Neurol India; 2016; 64(2):265-72. PubMed ID: 26954804
[TBL] [Abstract][Full Text] [Related]
6. Combination value of diffusion-weighted imaging and dynamic susceptibility contrast-enhanced MRI in astrocytoma grading and correlation with GFAP, Topoisomerase IIα and MGMT.
Qin JB; Zhang H; Wang XC; Tan Y; Wu XF
Oncol Lett; 2019 Sep; 18(3):2763-2770. PubMed ID: 31452754
[TBL] [Abstract][Full Text] [Related]
7. A multi-sequence and habitat-based MRI radiomics signature for preoperative prediction of MGMT promoter methylation in astrocytomas with prognostic implication.
Wei J; Yang G; Hao X; Gu D; Tan Y; Wang X; Dong D; Zhang S; Wang L; Zhang H; Tian J
Eur Radiol; 2019 Feb; 29(2):877-888. PubMed ID: 30039219
[TBL] [Abstract][Full Text] [Related]
8. Histogram analysis of diffusion kurtosis imaging derived maps may distinguish between low and high grade gliomas before surgery.
Qi XX; Shi DF; Ren SX; Zhang SY; Li L; Li QC; Guan LM
Eur Radiol; 2018 Apr; 28(4):1748-1755. PubMed ID: 29143940
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of the value of amide proton transfer-weighted imaging and diffusion kurtosis imaging in evaluating the histological grade of cervical squamous carcinoma.
Hou M; Song K; Ren J; Wang K; Guo J; Niu Y; Li Z; Han D
BMC Cancer; 2022 Jan; 22(1):87. PubMed ID: 35057777
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of the diffusion kurtosis imaging and diffusion tensor imaging in grading gliomas, predicting tumour cell proliferation and IDH-1 gene mutation status.
Zhao J; Wang YL; Li XB; Hu MS; Li ZH; Song YK; Wang JY; Tian YS; Liu DW; Yan X; Jiang L; Yang ZY; Chu JP
J Neurooncol; 2019 Jan; 141(1):195-203. PubMed ID: 30414095
[TBL] [Abstract][Full Text] [Related]
11. Grading and proliferation assessment of diffuse astrocytic tumors with monoexponential, biexponential, and stretched-exponential diffusion-weighted imaging and diffusion kurtosis imaging.
Zhang J; Chen X; Chen D; Wang Z; Li S; Zhu W
Eur J Radiol; 2018 Dec; 109():188-195. PubMed ID: 30527302
[TBL] [Abstract][Full Text] [Related]
12. Imaging parameters of high grade gliomas in relation to the MGMT promoter methylation status: the CT, diffusion tensor imaging, and perfusion MR imaging.
Moon WJ; Choi JW; Roh HG; Lim SD; Koh YC
Neuroradiology; 2012 Jun; 54(6):555-63. PubMed ID: 21833736
[TBL] [Abstract][Full Text] [Related]
13. Predicting O6-Methylguanine-DNA Methyltransferase Protein Expression in Primary Low- and High-Grade Gliomas Using Certain Qualitative Characteristics of Amide Proton Transfer-Weighted Magnetic Resonance Imaging.
Su L; Gao P; Lin S; Wu B; Qin W; Lin Y; Xue J
World Neurosurg; 2018 Aug; 116():e814-e823. PubMed ID: 29803064
[TBL] [Abstract][Full Text] [Related]
14. Differentiating high-grade glioma recurrence from pseudoprogression: Comparing diffusion kurtosis imaging and diffusion tensor imaging.
Wu XF; Liang X; Wang XC; Qin JB; Zhang L; Tan Y; Zhang H
Eur J Radiol; 2021 Feb; 135():109445. PubMed ID: 33341429
[TBL] [Abstract][Full Text] [Related]
15. Apparent diffusion coefficient obtained by magnetic resonance imaging as a prognostic marker in glioblastomas: correlation with MGMT promoter methylation status.
Romano A; Calabria LF; Tavanti F; Minniti G; Rossi-Espagnet MC; Coppola V; Pugliese S; Guida D; Francione G; Colonnese C; Fantozzi LM; Bozzao A
Eur Radiol; 2013 Feb; 23(2):513-20. PubMed ID: 22875158
[TBL] [Abstract][Full Text] [Related]
16. A correlation between diffusion kurtosis imaging and the proliferative activity of brain glioma.
Tonoyan AS; Pronin IN; Pitshelauri DI; Shishkina LV; Fadeeva LM; Pogosbekyan EL; Zakharova NE; Shults EI; Khachanova NV; Kornienko VN; Potapov AA
Zh Vopr Neirokhir Im N N Burdenko; 2015; 79(6):5-14. PubMed ID: 26977789
[TBL] [Abstract][Full Text] [Related]
17. MGMT activity, promoter methylation and immunohistochemistry of pretreatment and recurrent malignant gliomas: a comparative study on astrocytoma and glioblastoma.
Christmann M; Nagel G; Horn S; Krahn U; Wiewrodt D; Sommer C; Kaina B
Int J Cancer; 2010 Nov; 127(9):2106-18. PubMed ID: 20131314
[TBL] [Abstract][Full Text] [Related]
18. Diffusion weighted imaging in high-grade gliomas: A histogram-based analysis of apparent diffusion coefficient profile.
Gihr G; Horvath-Rizea D; Hekeler E; Ganslandt O; Henkes H; Hoffmann KT; Scherlach C; Schob S
PLoS One; 2021; 16(4):e0249878. PubMed ID: 33857203
[TBL] [Abstract][Full Text] [Related]
19. Diffusion kurtosis imaging as an imaging biomarker for predicting prognosis of the patients with high-grade gliomas.
Wang X; Gao W; Li F; Shi W; Li H; Zeng Q
Magn Reson Imaging; 2019 Nov; 63():131-136. PubMed ID: 31425809
[TBL] [Abstract][Full Text] [Related]
20. Diffusion kurtosis imaging combined with molecular markers as a comprehensive approach to predict overall survival in patients with gliomas.
Wang X; Li F; Wang D; Zeng Q
Eur J Radiol; 2020 Jul; 128():108985. PubMed ID: 32361603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
